IB Diffusion
Imaging Biometrics
Product specifications |
Information source:
Vendor
Last updated: July 31, 2020 |
General | |
---|---|
Product name | IB Diffusion |
Company | Imaging Biometrics |
Subspeciality | Multiple |
Modality | MR |
Disease targeted | Solid tumor |
Key-features | ADC calculations, parameter normalization |
Suggested use | |
Data characteristics | |
Population | tumors |
Input | Commonly acquired DWI datasets |
Input format | DICOM |
Output | Various parameter maps |
Output format | DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Hybrid solution |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | < 3 sec |
Certification | |
CE
|
Certified,
Class I
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 01-2013 |
Distribution channels | Eureka Clinical AI, QMENTA, Blackford Analysis, Medimsight, CorTechs Labs, aycan Medical Systems, Pixmeo, Calantic |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of users, Number of installations, Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |
|